Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Onyx Pharmaceuticals, Inc. (NQ: ONXX)
95.65 USD  +0.30 (+0.31%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Onyx Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Onyx Pharmaceuticals Announces Data Presentations at 49th American Society of Clinical Oncology Annual Meeting
May 15, 2013
from Marketwired News Releases
Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
May 08, 2013
Webcasts Available on Corporate Website Read More
from Marketwired News Releases
Onyx Pharmaceuticals Reports First Quarter 2013 Financial Results
May 07, 2013
Total Revenues Double to $145 Million; Kyprolis(R) Net Sales of $64 Million Read More
from Marketwired News Releases
Onyx Pharmaceuticals to Report First Quarter 2013 Financial Results After Market on May 7, 2013
April 16, 2013
Conference Call and Webcast at 5:00 p.m. Eastern Time Read More
from Marketwired News Releases
Today's Technical View on Sequenom, Peregrine Pharma, Inovio Pharma, and Onyx Pharma
April 12, 2013
from PR Newswire
Onyx Pharmaceuticals Announces Proteasome Inhibitor Data Presentations at 14th International Myeloma Workshop
April 01, 2013
Data on Carfilzomib and Oprozomib to Be Presented Read More
from Marketwired News Releases
Critical Alerts For Lowe's, Apollo Group, Darden Restaurants, Onyx Pharmaceuticals, and Ocwen Financial Released By InvestorsObserver
March 26, 2013
from PR Newswire
Bayer's Stivarga® (regorafenib) Tablets Approved in Japan
March 25, 2013
from PR Newswire
Innovative Product Portfolios Ride Commercialization & Global Expansion - Research Report on Amgen, Onyx Pharmaceuticals, Alexion Pharmaceuticals, BioMarin Pharmaceutical and Incyte
March 18, 2013
from PR Newswire
Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
March 14, 2013
from PR Newswire
Perfect Trade Setups, How to Play NKE, CCL, LMT and ONXX
March 12, 2013
from Marketwired News Releases
Drug Approvals, Breakthrough Treatments and Royalties - Research Report on Celgene Corporation, Onyx Pharmaceuticals, Sarepta Therapeutics, VIVUS and Achillion Pharmaceuticals
March 08, 2013
from PR Newswire
Onyx Pharmaceuticals to Host Analyst Day March 14, 2013
February 27, 2013
from Marketwired News Releases
Bayer's Stivarga® (regorafenib) Tablets Approved by U.S. FDA for Treatment of Patients with Locally Advanced, Unresectable or Metastatic GIST
February 25, 2013
from PR Newswire
Free Research Reports on COG, ONXX, TXN and WBMD Issued by the Bedford Report
February 25, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High
February 25, 2013
RDInvesting Provides Stocks Research on Onyx Pharmaceuticals and VIVUS Read More
from Marketwired News Releases
Onyx Pharmaceuticals Reports Full Year and Fourth Quarter 2012 Financial Results
February 21, 2013
Kyprolis(R) Net Sales Reach $64M in 2012; Nexavar(R) Continues Strong Regional Growth as Total Worldwide Sales Exceed $1B; Stivarga(R) Royalty Revenue of $8M in 2012 Read More
from Marketwired News Releases
Onyx Pharmaceuticals Announces Carfilzomib Study Published in the Medical Journal Leukemia Study Assessed Impact of Renal Function on Treatment in Relapsed/Refractory Myeloma Patients
February 20, 2013
from Marketwired News Releases
Onyx Pharmaceuticals Appoints Dr. Pablo Cagnoni as Executive Vice President, Global Research & Development and Technical Operations
February 15, 2013
from Marketwired News Releases
Critical Alerts For Verizon, United Continental, Garmin, Onyx Pharmaceuticals, and Darden Restaurants Released By InvestorsObserver
February 14, 2013
from PR Newswire
Free Research Report on Onyx Pharmaceuticals, Inc., Universal Health Services, Inc., Eastman Chemical Company, Varian Medical Systems, Inc. and Toronto-Dominion Bank (ON)
February 13, 2013
from Marketwired News Releases
Onyx Pharmaceuticals to Report Fourth Quarter and Full Year 2012 Financial Results After Market on February 21, 2013
February 07, 2013
Conference Call and Webcast at 5:00 p.m. Eastern Time Read More
from Marketwired News Releases
Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
February 05, 2013
Webcasts Available on Corporate Website Read More
from Marketwired News Releases
Onyx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
January 16, 2013
from Marketwired News Releases
Onyx Pharmaceuticals Announces Public Offering of Common Stock
January 15, 2013
from Marketwired News Releases
The Reason It Trades, What's Moving CLSN, ONXX, IMMU and NLNK
January 10, 2013
from Marketwired News Releases
Onyx Pharmaceuticals Announces 2013 Updates and Reviews 2012 Achievements at J.P. Morgan Healthcare Conference
January 07, 2013
Kyprolis(TM) (carfilzomib) for Injection Net Sales Exceed $62 Million for 2012 Read More
from Marketwired News Releases
Our Pros Knew RIG, GALE, GNC and ONXX Would Be Top Gainers on Friday
January 07, 2013
from Marketwired News Releases
Onyx Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
January 02, 2013
from Marketwired News Releases
Onyx Pharmaceuticals Announces N. Anthony Coles, M.D. Elected Chairman of Its Board of Directors
December 17, 2012
Paul Goddard, Ph.D., to Continue as Lead Independent Director Read More
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here